As the COVID-19 pandemic continues to rage across the world, the United States and its allies are pushing for answers about the virus's origins while China rebuffs inquiry into its early handling of the outbreak. Meanwhile, a growing U.S. stockpile of vaccines has opened new avenues for “vaccine diplomacy,” and the Biden administration has thrown its weight behind an effort to suspend cross-border intellectual property (IP) rules for vaccine manufacturing. In the near term, however, experts expect vaccination rates and access will continue to vary widely between countries depending on their wealth.

Kristen Eichensehr, United States Seeks Answers on COVID-19’s Origin While Stepping Up “Vaccine Diplomacy”, 115 American Journal of International Law, 732–739 (2021).
UVA Law Faculty Affiliations